Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

The phase 2/3 NRG GU002 trial (NCT03070886) evaluated whether adding 6 cycles of docetaxel after radiation and androgen ...

CHAPS, the leading prostate screening charity, is holding a unique workshop aiming to tackle the conflicting messages men are ...

HT Health Talk: Prostate cancer is common but often silent. Should you get checked earlier if your father or brother had it?

Kairos Pharma’s Phase II mCRPC data show ENV-105 plus apalutamide extended median PFS to 17.7 months versus 2 months. Read ...

I reject the idea that a man who keeps every prostate cancer surveillance appointment has ‘untreated cancer,’” writes Howard ...

CRPC Progression Patterns After Apalutamide in mCSPC / cancer, cancer care, Cancer research, cancer treatment, ...

Prostate cancer rates in young men across England have nearly quadrupled over the past two decades, concerning new research ...

Scientists from the World Cancer Research Fund found there were 640 new cases of the disease in 2023, up from 158 in 2001.

(NYSE American: KAPA), a clinical-stage biopharmaceutical company addressing drug resistance in cancer, today announced ...

A new theranostics suite is streamlining treatment and clinical trials for certain types of cancer, notably prostate cancer ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.